SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,616 | -29.3% | 15,676 | +1.9% | 0.00% | -33.3% |
| Q2 2023 | $322,134 | -1.8% | 15,391 | -1.0% | 0.00% | 0.0% |
| Q1 2023 | $328,205 | -4.9% | 15,540 | +14.5% | 0.00% | 0.0% |
| Q4 2022 | $345,280 | +10.7% | 13,567 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $312,000 | +33.9% | 12,989 | +7.3% | 0.00% | +50.0% |
| Q2 2022 | $233,000 | +25.3% | 12,105 | +13.3% | 0.00% | +100.0% |
| Q1 2022 | $186,000 | -18.8% | 10,681 | +2.0% | 0.00% | -50.0% |
| Q4 2021 | $229,000 | +13.9% | 10,470 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $201,000 | +14.2% | 10,514 | +2.6% | 0.00% | +100.0% |
| Q2 2021 | $176,000 | -16.6% | 10,247 | +8.6% | 0.00% | -50.0% |
| Q1 2021 | $211,000 | – | 9,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |